Skip to content
  • Off Canvas Toggle
  • +91 (2138) 675613
  • +91 (2138) 675614
  • +91 (2138) 675603
  • WhatsApp Form Panel
Murli Krishna Pharma LogoMurli Krishna Pharma LogoMurli Krishna Pharma Logo
  • Home
  • About Us
    Corporate Overview
    • Vision, Mission & Values
    • Infrastructure
    • Global Reach and Ongoing Projects
    • Regulatory Approvals and Audits
    • Corporate Social Responsibility
      • CSR Policy
      • Commitment to Sustainability
      • CSR Activities
    • Awards & Accolades
    • In The Media
    Team
    Dr. Satya Vadlamani
    Dr. Satya Vadlamani, CMD
    Dr. Vijay K. Shastri
    Dr. Vijay K. Shastri, Director and Technical Head
    Venkat Murli Krishna Vadlamani
    Dr.Venkat Murli Krishna, Director Strategy
    • Corporate Overview
    • Vision, Mission & Values
    • Infrastructure
    • Global Reach and Ongoing Projects
    • Regulatory Approvals and Audits
    • Corporate Social Responsibility (CSR)
      • Corporate Social Responsibility (CSR) Policy
      • Commitment to Sustainability
      • CSR Activities
    • Awards & Accolades
    • In The Media
    • Our Team
    • Chairperson and Managing Director
    • Director Technical
    • Director Strategy
    • Research and Development
      • R&D Highlights
      • Patents and Innovation
      • Products – Under Active Development
    • Quality
      • Quality Control
      • Quality Assurance
      • Quality Team
  • Products
    PFI Products
    FDF Products
    • Alpha Blockers
    • Anti Asthamatic
    • Anti Coagulants
    • Anti Depressants
    • Anti Fungal
    • Anti Hypertensives
    • Anti Inflammatory
    • Anti Obesity
    • Anticoagulants
    • Antiemetic
    • Carbonic Anhydrase Inhibitor
    • Corticosteroids
    • Digestant
    • Direct Thrombin Inhibitor
    • Immunosuppressant
    • Iron & Vitamin Supplements
    • Macrolide Antibiotic
    • Mitotic Inhibitor
    • NMDA Receptor Antagonist
    • Oncology
    • PFI Products – Alphabetical List
    • Products – Under Active Development
    • Oral Solid Dosage Formulations
      • Capsules
      • Tablets
      • Suspensions
    • Oral Liquid Dosage Formulations
    • Injectables
      • General Injectables
      • Injectable Suspensions
      • Oncology Injectables
    • Ophthalmic Suspensions & Solutions
    • Inhalation
    • Speciality Formulations
    • Support Therapy for Oncology
    • Topical Formulations
    • Pharmaceutical Formulation Intermediates
      • Alpha Blockers
      • Anti Asthamatic
      • Anti Depressants
      • Anti Fungal
      • Anti Hypertensives
      • Anti Inflammatory
      • Anti Obesity
      • Anti Ulcerant
      • Anticoagulants
      • Antiemetic
      • Carbonic Anhydrase Inhibitor
      • Corticosteroids
      • Digestant
      • Direct Thrombin Inhibitor
      • Immunosuppressant
      • Iron & Vitamin Supplements
      • Macrolide Antibiotic
      • Mitotic Inhibitor
      • NMDA Receptor Antagonist
      • Oncology
    • FDF Products
      • Oral Solid Dosage FormulationsWe manufacture a comprehensive range of oral solid dosage products, including tablets and capsules. Our Tablets, whether immediate-release, sustained-release, or modified-release formulations undergo stringent quality control measures to guarantee accurate dosing, uniform drug distribution, and optimal bioavailability. Our Capsules, manufactured by leveraging advanced encapsulation technologies offer versatility in drug delivery, enabling customized dosing and improved patient compliance.
      • Oral Liquid Dosage FormulationsOur oral liquid formulations are designed to cater to therapeutic needs of a wide range of patients with a focus on patient-centric care, pharmaceutical excellence, optimal bioavailability. Every step of the production process, from raw material selection to packaging and labelling is meticulously monitored and controlled to adhere to best practices and regulatory requirements, ensuring that our products meet or exceed international quality standards.
      • Injectables
      • Ophthalmic Suspensions & Solutions
      • Inhalation
      • Speciality Formulations
      • Topical Formulations
      • Support Therapy for Oncology
    • PFI Products – Alphabetical List
    • Products – Under Active Development
  • R&D
    • R&D Highlights
    • Patents and Innovation
    • Products – Under Active Development
  • Quality
    • Quality Assurance
    • Quality Team
  • CRAMS
  • Blogs
  • Contact Us
    • Contact Us
    • Information & Sample Request
    • Careers
      • Current Vacancies
    • Resources
  • Search

Blogs

BlogsMkppl-Atul2024-12-03T21:26:19+05:30
  • Donating laboratory equipment to Zilla Parishad School - Mar 2025
    Blog, CSR Activities

    Donating laboratory equipment to Zilla Parishad School

    Murli Krishna Pharma Pvt Ltd gifted computers and printers to ZP School in Lakhewadi, Shirur, Pune through its Corporate Social Responsibility (CSR) program. Initiating computer education to 53 students, this will enhance the educational experiences of the students at Zilla Parishad School.

    Read More
  • The Future of Non-Invasive Treatments
    Blog

    Revolutionizing Healthcare with Transdermal Delivery Systems: The Future of Non-Invasive Treatments

    Revolutionizing healthcare through innovative drug delivery systems (DDS) is a pressing need in today's medical landscape. Among the companies leading this on-going need is Murli Krishna Pharma Pvt. Ltd, a prominent player in the pharmaceutical sector that specializes in transdermal delivery systems. This method of drug administration allows for effective treatment while minimizing the invasiveness typically associated with traditional methods.

    Read More
  • How is Dr. Satya Vadlamani's Leadership transforming Murli Krishna Pharma Pvt. Ltd
    Blog

    How is Dr. Satya Vadlamani’s Leadership transforming Murli Krishna Pharma Pvt. Ltd?

    Dr. Satya Vadlamani, Chairperson and Managing Director of Murli Krishna Pharma Pvt. Ltd. (MKPPL) has been instrumental in transforming the company into a leading pharmaceutical manufacturer and contract research organization. With her unwavering commitment to innovation, quality, and social responsibility, Dr. Vadlamani has steered MKPPL to new heights, making it a beacon of excellence in the industry.

    Read More
  • India Today - Aug 2024
    Blog, Media

    Maxing the Potential of Nano Technology in Pharma – India Today – Aug 2024

    Maxing the Potential of Nano Technology in Pharma - Dr. Satya Vadlamani - Article in India Today in their Aug 2024 issue.

    Read More
  • Ensuring Quality and Compliance A Look Inside Murli Krishna Pharma’s EU and WHO Approved Facilities
    Blog

    Ensuring Quality and Compliance: A Look Inside Murli Krishna Pharma’s EU and WHO Approved Facilities

    Murli Krishna Pharma has established itself as a prominent player in the pharma industry, particularly noted for its ‘commitment to quality and compliance’. With facilities accredited by the European Union (EU) and the World Health Organization (WHO), the company exemplifies excellence in pharmaceutical manufacturing, ensuring that its products meet stringent international standards.

    Read More
  • Pioneering Innovation The Story Behind Murli Krishna Pharma’s Groundbreaking Research and Development
    Blog

    Pioneering Innovation: The Story Behind Murli Krishna Pharma’s Groundbreaking Research and Development

    Murli Krishna Pharma has emerged as a pioneering force in the pharmaceutical industry, particularly known for its innovative Research and Development (R&D) initiatives, with over 200+ happy customers, across 78+ countries. Founded in 2004 by Dr. Satya Vadlamani, CMD and Dr. Vijay K. Shastri, the company has dedicated itself to creating 34+ high-quality pharmaceutical products, that meet international standards like “European Union, WHO, GCC and Jordanian FDA”. This commitment to excellence is reflected in its extensive range of offerings, including “Pre-finished Formulation Intermediates and Finished Dosage forms”.

    Read More
  • Murli Krishna Pharma is gearing up to support Anemia Mukt Bharat Mission
    Blog

    Murli Krishna Pharma is gearing up to support Anemia Mukt Bharat Mission

    Murli Krishna Pharma Pvt. Ltd, a leading Indian pharmaceutical company, is playing a pivotal role in supporting the Anemia Mukt Bharat (AMB) mission, a nationwide initiative spearheaded by the Ministry of Health and Family Welfare and UNICEF.

    Read More
  • Murli Krishna Pharma Pioneering Solutions for Anemia-Free India
    Blog

    Murli Krishna Pharma Pioneering Solutions for Anemia-Free India

    Murli Krishna Pharma Pvt. Ltd, a leading Indian pharmaceutical company, has been at the forefront of combating anemia in the country. With a strong focus on public health and innovation, the company has developed groundbreaking solutions to support the National Health Mission and the government's vision of an Anemia Mukt Bharat, as envisioned by PM Modi and the Ministry of Health and Family Welfare.

    Read More
  • Amenia Mukt Bharat a Nationwide Movement Towards a Healthier India
    Blog

    Amenia Mukt Bharat a Nationwide Movement Towards a Healthier India

    Anemia Mukt Bharat (AMB) initiative, launched by the Ministry of Health and Family Welfare in 2018, is a nationwide movement towards a healthier India. This ambitious program aims to eliminate anemia among key population groups, including pregnant women, children, and adolescents, through a comprehensive 6x6x6 strategy.

    Read More
12Next
Golden Rectangle thin 2

Murli Krishna Pharma

  • Factory Address :

    Murli Krishna Pharma Private Ltd.

    D-98, MIDC Ranjangaon,
    Taluka – Shirur, Dist. Pune – 412209
    Maharashtra. India.

  • +91 (2138) 675613
  • +91 (2138) 675614

  • +91 (2138) 675603

  • info@mkppl.com

  • marketing@mkppl.com

Upcoming Events

No Events Scheduled Currently…

Quick Links

  • PFI Products
  • FDF Products
  • Careers
  • Events
  • Feedback
  • Disclaimer
  • Privacy Policy
All information and material on this site is provided on an “as is” basis, and without guarantees or warranties of any kind, express or implied. Furthermore, any ideas and/or information provided or gained from this site would not necessarily reflect the views of Murli Krishna Pharma Pvt. Ltd. or its directors or employees.
|
The materials and/or information available or obtained at/through this site is/are not guaranteed or warranted in terms of completeness, correctness, accuracy, reliability or otherwise howsoever by Murli Krishna Pharma Pvt. Ltd. or its directors or employees.
|
The information presented on this web site does not constitute an offer for sale in territories where it is not permitted by Patent Law.

© 2016 - 2025 - Murli Krishna Pharma • All Rights Reserved | Website designed & maintained by Mediavault

Page load link

Factory Address

  • Murli Krishna Pharma Private Ltd.
    D-98, MIDC Ranjangaon,
    Taluka – Shirur, Dist. Pune – 412209
    Maharashtra. India.

  • +91 (2138) 675613

  • +91 (2138) 675614

  • +91 (2138) 675603
  • +91 (2138) 670359

  • info@mkppl.com
  • marketing@mkppl.com
  • Murlikrishna Pharma

Business Card

  • Download Business Card

Connect Via WhatsApp

  • https://wa.me/91919191000

WhatsApp Us

Search


This website uses cookies and third party services. Please refer to our Privacy Policy for more information Settings Accept All Decline

Necessary Cookies

These cookies are necessary for the proper functioning of this website and better user experience. By continuing to browse this website you agree to their usage. For details please refer to our Privacy Policy.

Tracking Cookies

These cookies allows the website to remember user preferences, track user behavior across the site. The primary purpose of tracking cookies is to enable personalized experiences and website analytics.

Third Party Embeds

The website uses Third Party Embeds to present rich media content. You can control the data collected by these third party services by selecting the choices below. If you choose not to opt in now, you may opt in when you decide to interact with the content on the website.
Go to Top